LCOV
ELV icon

London Company of Virginia’s Elevance Health ELV Stock Holding History

London Company of Virginia’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,857
Closed -$287K – 143
2015
Q1 		$287K Buy
+1,857
New +$264K ﹤0.01% 122

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

London Company of Virginia's ELV Position: Q2 2015 in Review

London Company of Virginia sold out of Elevance Health (ELV) in Q2 2015, closing a stake of 1,857 shares — an estimated $287K sold.

London Company of Virginia first reported a position in ELV in Q1 2015 and held it in 1 quarter. The position peaked at $287K in Q1 2015. 781 funds tracked by Wall St. Rank hold ELV as of Q2 2015.

  • London Company of Virginia reported no remaining Elevance Health position as of Q2 2015 after selling out during the quarter.
  • London Company of Virginia sold 1,857 Elevance Health shares in Q2 2015, an estimated $287K.
  • London Company of Virginia first reported a position in Elevance Health in Q1 2015 and held it in 1 quarter.
  • London Company of Virginia's Elevance Health position peaked at $287K in Q1 2015.
  • 781 funds tracked by Wall St. Rank held Elevance Health as of Q2 2015.

Based on London Company of Virginia's 13F filing for Q2 2015, filed 14 Aug 2015.